The Centre’s placing of an order for five crore doses of the pediatric vaccine Corbevax has rekindled debate on vaccinating young children, even as experts pointed to the radical nature of Omicron that challenges the extent of protection inoculations can offer. Corbevax is a protein sub-unit vaccine developed in the United States and licensed to the Indian firm, Biological E
The launch of the booster shot campaign and new vaccines give hope that the impact of Omicron and the third wave will be less severe than the previous surge - Issue Date: Jan 24, 2022
This is the third year that we have been living with the virus, which is showing no signs of relenting. Instead of showing a letup, it is only spiralling. The intensity seems to be getting sharper. One has to be resigned to live with it. The indications are very distressing.
In India the first dose of the Covid vaccine - rolled out from January 16 last year amid concerns over delays in vaccination - was "essentially a booster", Dr Jayaprakash Muliyil of the Indian Council for Medical Research (ICMR), told NDTV.